Clinical Trial

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Study acronym: IDEAL
Recruiting
View on ClinicalTrials.gov →
Summary
A multi-center, prospective, observer-blinded, randomized controlled clinical trial to evaluate the efficacy of PPECM augmented standard of care versus standard of care alone in the management of hard-to-heal diabetic foot ulcers.
Protocol Amendment History 4 changes
notable Enrollment increased: 194 -> 235 participants 2026-08-12
notable Trial sites expanded: 9 -> 21 locations 2026-08-12
notable Primary completion pushed: 2026-02 -> 2027-05 2026-08-12
minor Completion pushed: 2026-07 -> 2028-01 2026-08-12
Trial Details
NCT Number NCT06616844
Lead Sponsor ConvaTec Inc.
Conditions Wound Heal, Ulcer
Enrollment 235 participants
Start Date 2025-02-12
Primary Completion 2027-05 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11